We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Sensus Healthcare Inc (SRTS) USD0.01

Sell:$7.38 Buy:$7.57 Change: $0.51 (7.40%)
Market closed |  Prices as at close on 2 December 2021 | Switch to live prices |
Change: $0.51 (7.40%)
Market closed |  Prices as at close on 2 December 2021 | Switch to live prices |
Change: $0.51 (7.40%)
Market closed |  Prices as at close on 2 December 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Sensus Healthcare, Inc. is a medical device company. The Company is focused on providing non-invasive treatments for both oncological and non-oncological skin conditions. The Company uses a low-energy X-ray technology known as superficial radiation therapy (SRT). The Company incorporated SRT into its portfolio of treatment devices: the SRT-100, SRT-100 Plus and SRT-100 Vision. The Company's product, SRT-100, is a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its other two products, such as SRT-100 Plus and SRT-100 Vision provides customers with additional options compared to the SRT-100 base model.

Contact details

851 Broken Sound Pkwy NW Ste 215
United States
+1 (561) 9225808

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$95.88 million
Shares in issue:
16.62 million
Health Care Equipment
United States
US dollar

Key personnel

  • Joseph Sardano
    Chairman of the Board, President, Chief Executive Officer, Co-Founder
  • Stephen Cohen
    Co-Founder, Executive Vice President - Strategic Initiatives and Dermatology Sales
  • Javier Rampolla
    Chief Financial Officer
  • Nicolas Soro
    Chief Operating Officer
  • Yonatan Vainer
    Chief Technology Officer
  • Michael Sardano
    Vice President, General Counsel, Director of Governance and Regulatory

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.